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Background: Transcatheter balloon aortic valvuloplasty (BAVP) is the preferred treatment for congenital aortic stenosis (AS). Aortic valve function 
and reintervention late after this procedure are not well characterized.
Methods: Retrospective review of 563 patients who underwent BAVP for congenital AS from 1985-2008.
Results: After exclusion of those converted to a univentricular circulation and/or died within 30 days, 509 patients comprised the study cohort. 
Median follow-up was 9.3 years (0.1-23.6 years); cumulative follow-up was 5003 patient-years. Median age was 2.4 years (1 day-40.5 years) and 
most patients (73%) had isolated native AS. Peak AS gradients decreased significantly after dilation (median decrease 35 mmHg). Acute post-
dilation aortic regurgitation (AR) was moderate or greater in 70 (14%), and more common in older patients (p<0.001). During follow-up, 225 (44%) 
underwent any aortic valve reintervention: repeat BAVP in 115, aortic valve repair in 65, and aortic valve replacement in 116. Survival free from 
any surgical aortic valve reintervention (repair or replacement) was 82±2% at 5 years, 69±3% at 10 years, and 46±4% at 20 years. In multivariate 
analyses, lower post-dilation AS gradient, lower grade of post-dilation AR, and absence of multiple left heart obstructive lesions were associated with 
longer freedom from surgical aortic valve reintervention, but age, era, and pre-dilation AS severity were not.
Conclusions: While transcatheter BAVP is effective for relief of congenital AS, there are steady long-term hazards for surgical aortic valve 
reintervention and replacement that are independent of age at initial intervention or AS severity.
